FDA Drug recall D-0114-2017
DIPYRIDAMOLE Tablets USP, 75 mg, 100-count bottle, Rx only, Dist. by: Roxane Laboratories, Inc., Columbus, Ohio 43216, NDC 0054-0436-25
- FDA Drug
- Class II
- terminated
- Published 2016-11-02
On 2016-11-02 the FDA classified a Class II recall of DIPYRIDAMOLE Tablets USP, 75 mg, 100-count bottle, Rx only, Dist. by: Roxane Laboratories, Inc., Columbus, Ohio 43216, NDC 0054-0436-25 by Boehringer Ingelheim Pharmaceuticals, citing presence of foreign tablets/capsules: 50 mg Persantine tablets were found in a 75 mg Persantine 100-count bottle and 50 mg Persantine tablet was found in a 100 count bottle of 75….
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0114-2017 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2016-10-06 |
| Published | 2016-11-02 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Boehringer Ingelheim Pharmaceuticals |
| Distribution | US |
Product
DIPYRIDAMOLE Tablets USP, 75 mg, 100-count bottle, Rx only, Dist. by: Roxane Laboratories, Inc., Columbus, Ohio 43216, NDC 0054-0436-25
Reason
Presence of foreign tablets/capsules: 50 mg Persantine tablets were found in a 75 mg Persantine 100-count bottle and 50 mg Persantine tablet was found in a 100 count bottle of 75 mg Dipyridamole.
Identifiers
| code_info | Lot #: 554820, Exp 5/17 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0114-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.